BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 33172482)

  • 1. Time interval-based indication for liver resection of metastasis from pancreatic cancer.
    Mitsuka Y; Yamazaki S; Yoshida N; Yan M; Higaki T; Takayama T
    World J Surg Oncol; 2020 Nov; 18(1):294. PubMed ID: 33172482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surgical resection for liver recurrence after curative resection of pancreatic ductal adenocarcinoma.
    Shibata Y; Uemura K; Sumiyoshi T; Okada K; Otsuka H; Serikawa M; Ishii Y; Murakami Y; Arihiro K; Takahashi S
    Langenbecks Arch Surg; 2023 Jul; 408(1):280. PubMed ID: 37458812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resection of pancreatic ductal adenocarcinoma with synchronous distant metastasis: is it worthwhile?
    Buc E; Orry D; Antomarchi O; Gagnière J; Da Ines D; Pezet D
    World J Surg Oncol; 2014 Nov; 12():347. PubMed ID: 25407113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oligometastatic pulmonary metastasis in pancreatic cancer patients: Safety and outcome of resection.
    Ilmer M; Schiergens TS; Renz BW; Schneider C; Sargut M; Waligora R; Weniger M; Hartwig W; Ceyhan GO; Friess H; Werner J; D'Haese JG
    Surg Oncol; 2019 Dec; 31():16-21. PubMed ID: 31473583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preoperative evaluation of pancreatic ductal adenocarcinoma with synchronous liver metastasis: Diagnosis and assessment of unresectability.
    Shi HJ; Jin C; Fu DL
    World J Gastroenterol; 2016 Dec; 22(45):10024-10037. PubMed ID: 28018110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different clinical presentations of metachronous pulmonary metastases after resection of pancreatic ductal adenocarcinoma: Retrospective study and review of the literature.
    Lovecek M; Skalicky P; Chudacek J; Szkorupa M; Svebisova H; Lemstrova R; Ehrmann J; Melichar B; Yogeswara T; Klos D; Vrba R; Havlik R; Mohelnikova-Duchonova B
    World J Gastroenterol; 2017 Sep; 23(35):6420-6428. PubMed ID: 29085191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinicopathological variables and risk factors for lung recurrence after resection of pancreatic ductal adenocarcinoma.
    Asakura Y; Toyama H; Ishida J; Asari S; Terai S; Shirakawa S; Yamashita H; Shimizu T; Ogura Y; Matsumoto I; Gon H; Tsugawa D; Komatsu S; Kuramitsu K; Yanagimoto H; Kido M; Ajiki T; Fukumoto T
    Asian J Surg; 2023 Jan; 46(1):207-212. PubMed ID: 35370072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patterns, Timing, and Predictors of Recurrence Following Pancreatectomy for Pancreatic Ductal Adenocarcinoma.
    Groot VP; Rezaee N; Wu W; Cameron JL; Fishman EK; Hruban RH; Weiss MJ; Zheng L; Wolfgang CL; He J
    Ann Surg; 2018 May; 267(5):936-945. PubMed ID: 28338509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Second pancreatectomy for recurrent pancreatic ductal adenocarcinoma in the remnant pancreas: A pooled analysis.
    Zhou Y; Song A; Wu L; Si X; Li Y
    Pancreatology; 2016; 16(6):1124-1128. PubMed ID: 27717684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective reoperation for locally recurrent or metastatic pancreatic ductal adenocarcinoma following primary pancreatic resection.
    Thomas RM; Truty MJ; Nogueras-Gonzalez GM; Fleming JB; Vauthey JN; Pisters PW; Lee JE; Rice DC; Hofstetter WL; Wolff RA; Varadhachary GR; Wang H; Katz MH
    J Gastrointest Surg; 2012 Sep; 16(9):1696-704. PubMed ID: 22644446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of completion pancreatectomy for recurrence of adenocarcinoma in the remnant pancreas.
    Nakayama Y; Sugimoto M; Gotohda N; Konishi M; Takahashi S
    J Surg Res; 2018 Jan; 221():15-23. PubMed ID: 29229121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patients with hepatic oligometastatic pancreatic body/tail ductal adenocarcinoma may benefit from synchronous resection.
    Yang J; Zhang J; Lui W; Huo Y; Fu X; Yang M; Hua R; Wang L; Sun Y
    HPB (Oxford); 2020 Jan; 22(1):91-101. PubMed ID: 31262486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metachronous hepatic resection for liver only pancreatic metastases.
    Schwarz C; Fitschek F; Primavesi F; Stättner S; Margonis GA; Weiss MA; Stavrou GA; Oldhafer KJ; Kornprat P; Wundsam H; Fischer I; Längle F; Függer R; Hauer A; Klug R; Kieler M; Prager G; Schindl M; Stremitzer S; Bodingbauer M; Sahora K; Kaczirek K
    Surg Oncol; 2020 Dec; 35():169-173. PubMed ID: 32889249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical characteristics of initial recurrence in lung after surgical resection for pancreatic ductal adenocarcinoma.
    Otsuka H; Uemura K; Kondo N; Sumiyoshi T; Nakagawa N; Okada K; Seo S; Murakami Y; Takahashi S
    Pancreatology; 2020 Oct; 20(7):1472-1478. PubMed ID: 32900632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival Impact of Pulmonary Metastasis as Recurrence of Pancreatic Ductal Adenocarcinoma.
    Yamashita K; Miyamoto A; Hama N; Asaoka T; Maeda S; Omiya H; Takami K; Doki Y; Mori M; Nakamori S
    Dig Surg; 2015; 32(6):464-71. PubMed ID: 26517228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of adjacent organ resection in patients with left-sided pancreatic ductal adenocarcinoma following distal pancreatectomy.
    Song KB; Kwon J; Kim YW; Hwang DW; Lee JH; Hong S; Lee JW; Hwang K; Yoo D; Kim SC
    J Hepatobiliary Pancreat Sci; 2019 Jun; 26(6):227-234. PubMed ID: 30980486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perineural Invasion of Pancreatic Ductal Adenocarcinoma is Associated with Early Recurrence after Neoadjuvant Therapy Followed by Resection.
    Cha DE; Yu AT; Khajoueinejad N; Gleeson E; Shaltiel T; Berger Y; Macfie R; Golas BJ; Sarpel U; Labow DM; Hiotis S; Cohen NA
    World J Surg; 2023 Jul; 47(7):1801-1808. PubMed ID: 37014430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-Term Survivors after Upfront Resection for Pancreatic Ductal Adenocarcinoma: An Actual 5-Year Analysis of Disease-Specific and Post-Recurrence Survival.
    Belfiori G; Crippa S; Francesca A; Pagnanelli M; Tamburrino D; Gasparini G; Partelli S; Andreasi V; Rubini C; Zamboni G; Falconi M
    Ann Surg Oncol; 2021 Dec; 28(13):8249-8260. PubMed ID: 34258720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes of lung metastasis from pancreatic cancer: A nationwide multicenter analysis.
    Homma Y; Endo I; Matsuyama R; Sho M; Mizuno S; Seyama Y; Hirano S; Aono T; Kitami C; Morita Y; Takeda Y; Yoshida K; Tani M; Kaiho T; Yamamoto Y; Aoki H; Ogawa M; Niguma T; Mataki Y; Kawasaki H; Baba H; Yokomizo H; Rikiyama T; Yamaue H; Yamamoto M
    J Hepatobiliary Pancreat Sci; 2022 May; 29(5):552-561. PubMed ID: 35179827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oncologic resection of pancreatic cancer with isolated liver metastasis: Favorable outcomes in select patients.
    Nagai M; Wright MJ; Ding D; Thompson ED; Javed AA; Weiss MJ; Hruban RH; Yu J; Burkhart RA; He J; Cameron JL; Wolfgang CL; Burns WR
    J Hepatobiliary Pancreat Sci; 2023 Aug; 30(8):1025-1035. PubMed ID: 36652559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.